The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $214,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, San Francisco (UCSF). The grant aims to leverage the Seasonal Malaria Chemoprevention (SMC) platform to deliver co-interventions that may augment the efficacy of SMC and reduce the incidence of malaria and malnutrition in children in the Sahel region of Africa. The project will conduct a pilot trial to evaluate how the existing SMC delivery system, which involves monthly door-to-door distribution of antimalarial drugs to children aged 3-59 months, can be utilized to also provide nutritional interventions during the high-risk rainy season. The goal is to provide optimal protection for children during this vulnerable period by delivering a combined approach on an established platform that reaches millions of children each month. The award has a start date of December 4, 2024 and an ultimate completion date of November 30, 2026.
Generated 3/4/25, 2:47 AM